Erwiderung auf den Leserbrief zum Beitrag „Neue Therapieoption für akute hepatische Porphyrien“

Ulrich Stölzel; Detlef Schuppan

doi:10.1055/a-1585-8256

DMW – Klinischer Fortschritt, Table of Contents

Dtsch Med Wochenschr 2021; 146(23): 1578-1579
DOI: 10.1055/a-1585-8256

Leserbrief

Erwiderung auf den Leserbrief zum Beitrag „Neue Therapieoption für akute hepatische Porphyrien“

Ulrich Stölzel

¹Porphyriezentrum, Klinikum Chemnitz gGmbH, Chemnitz

,

Detlef Schuppan

²Institut für Translationale Immunologie, Zentrum für Zöliakie, Dünndarmerkrankungen und Autoimmunität, Johannes-Gutenberg-Universität, Mainz

³Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

› Author Affiliations

Abstract

Full Text

References

Literatur
1 To-Figueras J, Lopez RM, Deulofeu R. et al. Preliminary report: hyperhomocysteinemia in patients with acute intermittent porphyria. Metabolism 2010; 59: 1809-1810
2 Martí-Carvajal AJ, Solà I, Lathyris D. et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2017; 8: CD006612
3 Ospina-Romero M, Cannegieter SC, den Heijer M. et al. Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors. Am J Epidemiol 2018; 187: 1392-1400
4 Sacharow SJ, Picker JD, Levy HL. Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency. In: Adam MP, Ardinger HH, Pagon RA. et al. Hrsg. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993. Im Internet (Stand: 01.09.2021): http://www.ncbi.nlm.nih.gov/books/NBK1524/
5 Kim J, Kim H, Roh H. et al. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res 2018; 41: 372-383
6 Vassiliou D, Sardh E. Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta-synthase. J Intern Med 2021;
7 Marsden JT, Guppy S, Stein P. et al. Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms. JIMD Rep 2015; 22: 57-65
8 Petrides PE, Klein M, Schuhmann E. et al. Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?. Ann Hematol 2021; 100: 1685-1693
9 Neitzke G. [Indication: scientific and ethical basis of medical practice]. Med Klin Intensivmed Notfmed 2014; 109: 8-12